Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2020

01-12-2020 | Antibiotic | Research

Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) among undocumented migrants and uninsured legal residents in Amsterdam, the Netherlands: a cross-sectional study

Authors: E. van Dulm, S. Klok, A. Boyd, I. K. Joore, M. Prins, A. P. van Dam, G. A. Tramper-Stranders, Y. T. H. P. van Duijnhoven

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2020

Login to get access

Abstract

Background

Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) is associated with an increased risk of infection. Colonization with MRSA is observed in < 1% of the general Dutch population. Increased risk for MRSA carriage is known to occur in several key groups, one of which is asylum seekers. However, little is known about MRSA carriage among undocumented migrants and uninsured legal residents. This study aimed to determine the prevalence of nasal MRSA carriage among these groups in Amsterdam, the Netherlands.

Methods

In this cross-sectional study, between October 2018 and October 2019, undocumented migrants and uninsured legal residents aged 18 years or older who were able to understand one of the study languages were recruited at an NGO health care facility in Amsterdam, the Netherlands, for general practitioner (GP) consultations. Participants were asked questions on demographics, migration history, antibiotic use and other possible risk factors for MRSA carriage and were screened for nasal MRSA carriage by selective culturing e-swabs. Characteristics of MRSA-negative and MRSA-positive participants were compared using univariable logistic regression analysis with Firth’s correction.

Results

Of the 3822 eligible patients, 760 were screened for nasal MRSA carriage (19.9%). Of the 760 participants, over half were male (58%; 442/760) and originated mainly from Africa (35%; 267/760), Asia (30%; 229/760) and North or South America (30%; 227/760). In total, 705/760 participants (93%) were undocumented migrants and 55/760 (7%) were uninsured legal residents of Amsterdam. The overall prevalence of nasal MRSA carriage was 2.0% (15/760) (95%CI 1.1 to 3.2%), with no difference between undocumented migrants (14/705) (2.0, 95%CI 1.1 to 3.3%) and uninsured legal residents (1/55) (1.8, 95%CI 0.1 to 9.7%). Genotyping showed no clustering of the 15 isolates. MRSA carriage was not associated with sociodemographic, migration history or other possible risk factors. Nevertheless, this study had limited power to detect significant determinants. Three participants (3/15; 20%) harbored Panton-Valentine leukocidin (PVL)-positive isolates.

Conclusion

Even though our study population of undocumented migrants and uninsured legal residents had a higher prevalence of nasal MRSA carriage compared to the general Dutch population, the prevalence was relatively low compared to acknowledged other high-risk groups.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5(12):751–62.PubMedCrossRef Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5(12):751–62.PubMedCrossRef
2.
go back to reference Cassini A, Hogberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.PubMedPubMedCentralCrossRef Cassini A, Hogberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.PubMedPubMedCentralCrossRef
3.
go back to reference Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004;364(9435):703–5.PubMedCrossRef Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004;364(9435):703–5.PubMedCrossRef
4.
go back to reference von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group N Engl J Med. 2001;344(1):11–6.CrossRef von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group N Engl J Med. 2001;344(1):11–6.CrossRef
5.
go back to reference Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004;56(4):321–5.PubMedCrossRef Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004;56(4):321–5.PubMedCrossRef
6.
go back to reference Guideline on methicillin-resistant Staphylococcus aureus (MRSA). Dutch Working Group Infection Prevention (WIP) 2012. Guideline on methicillin-resistant Staphylococcus aureus (MRSA). Dutch Working Group Infection Prevention (WIP) 2012.
7.
go back to reference Brauer R, Ruigomez A, Downey G, Bate A, Garcia Rodriguez LA, Huerta C, et al. Prevalence of antibiotic use: a comparison across various European health care data sources. Pharmacoepidemiol Drug Saf. 2016;25(Suppl 1):11–20.PubMedCrossRef Brauer R, Ruigomez A, Downey G, Bate A, Garcia Rodriguez LA, Huerta C, et al. Prevalence of antibiotic use: a comparison across various European health care data sources. Pharmacoepidemiol Drug Saf. 2016;25(Suppl 1):11–20.PubMedCrossRef
8.
go back to reference Bode LG, Wertheim HF, Kluytmans JA, Bogaers-Hofman D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Sustained low prevalence of meticillin-resistant Staphylococcus aureus upon admission to hospital in the Netherlands. J Hosp Infect. 2011;79(3):198–201.PubMedCrossRef Bode LG, Wertheim HF, Kluytmans JA, Bogaers-Hofman D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Sustained low prevalence of meticillin-resistant Staphylococcus aureus upon admission to hospital in the Netherlands. J Hosp Infect. 2011;79(3):198–201.PubMedCrossRef
9.
go back to reference Weterings V, Veenemans J, van Rijen M, Kluytmans J. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus in patients at hospital admission in the Netherlands, 2010-2017: an observational study. Clin Microbiol Infect. 2019. Weterings V, Veenemans J, van Rijen M, Kluytmans J. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus in patients at hospital admission in the Netherlands, 2010-2017: an observational study. Clin Microbiol Infect. 2019.
10.
go back to reference Ravensbergen SJ, Berends M, Stienstra Y, Ott A. High prevalence of MRSA and ESBL among asylum seekers in the Netherlands. PLoS One. 2017;12(4):e0176481.PubMedPubMedCentralCrossRef Ravensbergen SJ, Berends M, Stienstra Y, Ott A. High prevalence of MRSA and ESBL among asylum seekers in the Netherlands. PLoS One. 2017;12(4):e0176481.PubMedPubMedCentralCrossRef
11.
go back to reference Nellums LB, Thompson H, Holmes A, Castro-Sanchez E, Otter JA, Norredam M, et al. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(7):796–811.PubMedPubMedCentralCrossRef Nellums LB, Thompson H, Holmes A, Castro-Sanchez E, Otter JA, Norredam M, et al. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18(7):796–811.PubMedPubMedCentralCrossRef
12.
go back to reference Danielsen AS, Elstrom P, Arnesen TM, Gopinathan U, Kacelnik O. Targeting TB or MRSA in Norwegian municipalities during ‘the refugee crisis’ of 2015: a framework for priority setting in screening. Euro Surveill. 2019;24(38). Danielsen AS, Elstrom P, Arnesen TM, Gopinathan U, Kacelnik O. Targeting TB or MRSA in Norwegian municipalities during ‘the refugee crisis’ of 2015: a framework for priority setting in screening. Euro Surveill. 2019;24(38).
13.
go back to reference Aro T, Kantele A. High rates of meticillin-resistant Staphylococcus aureus among asylum seekers and refugees admitted to Helsinki University Hospital, 2010 to 2017. Euro Surveill. 2018;23(45). Aro T, Kantele A. High rates of meticillin-resistant Staphylococcus aureus among asylum seekers and refugees admitted to Helsinki University Hospital, 2010 to 2017. Euro Surveill. 2018;23(45).
14.
go back to reference Johnston V. Australian asylum policies: have they violated the right to health of asylum seekers? Aust N Z J Public Health. 2009;33(1):40–6.PubMedCrossRef Johnston V. Australian asylum policies: have they violated the right to health of asylum seekers? Aust N Z J Public Health. 2009;33(1):40–6.PubMedCrossRef
15.
16.
go back to reference Hacker K, Chu J, Leung C, Marra R, Pirie A, Brahimi M, et al. The impact of immigration and customs enforcement on immigrant health: perceptions of immigrants in Everett, Massachusetts, USA. Soc Sci Med. 2011;73(4):586–94.PubMedPubMedCentralCrossRef Hacker K, Chu J, Leung C, Marra R, Pirie A, Brahimi M, et al. The impact of immigration and customs enforcement on immigrant health: perceptions of immigrants in Everett, Massachusetts, USA. Soc Sci Med. 2011;73(4):586–94.PubMedPubMedCentralCrossRef
18.
go back to reference Badiaga S, Raoult D, Brouqui P. Preventing and controlling emerging and reemerging transmissible diseases in the homeless. Emerg Infect Dis. 2008;14(9):1353–9.PubMedPubMedCentralCrossRef Badiaga S, Raoult D, Brouqui P. Preventing and controlling emerging and reemerging transmissible diseases in the homeless. Emerg Infect Dis. 2008;14(9):1353–9.PubMedPubMedCentralCrossRef
19.
go back to reference Coppola N, Alessio L, Gualdieri L, Pisaturo M, Sagnelli C, Caprio N, et al. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013. Euro Surveill. 2015;20(35). Coppola N, Alessio L, Gualdieri L, Pisaturo M, Sagnelli C, Caprio N, et al. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013. Euro Surveill. 2015;20(35).
20.
go back to reference Coppola N, Alessio L, Gualdieri L, Pisaturo M, Sagnelli C, Minchini C, et al. Hepatitis B virus infection in undocumented immigrants and refugees in southern Italy: demographic, virological, and clinical features. Infect Dis Poverty. 2017;6. Coppola N, Alessio L, Gualdieri L, Pisaturo M, Sagnelli C, Minchini C, et al. Hepatitis B virus infection in undocumented immigrants and refugees in southern Italy: demographic, virological, and clinical features. Infect Dis Poverty. 2017;6.
21.
go back to reference El-Hamad I, Pezzoli MC, Chiari E, Scarcella C, Vassallo F, Puoti M, et al. Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy. J Travel Med. 2015;22(2):78–86.PubMedCrossRef El-Hamad I, Pezzoli MC, Chiari E, Scarcella C, Vassallo F, Puoti M, et al. Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy. J Travel Med. 2015;22(2):78–86.PubMedCrossRef
22.
go back to reference van de Sande JSO, van den Muijsenbergh M. Undocumented and documented migrants with chronic diseases in family practice in the Netherlands. Fam Pract. 2017;34(6):649–55.PubMedCrossRef van de Sande JSO, van den Muijsenbergh M. Undocumented and documented migrants with chronic diseases in family practice in the Netherlands. Fam Pract. 2017;34(6):649–55.PubMedCrossRef
23.
go back to reference Schoevers MA, van den Muijsenbergh ME, Lagro-Janssen AL. Self-rated health and health problems of undocumented immigrant women in the Netherlands: a descriptive study. J Public Health Policy. 2009;30(4):409–22.PubMedCrossRef Schoevers MA, van den Muijsenbergh ME, Lagro-Janssen AL. Self-rated health and health problems of undocumented immigrant women in the Netherlands: a descriptive study. J Public Health Policy. 2009;30(4):409–22.PubMedCrossRef
24.
go back to reference Kluytmans-van den Bergh MF, Vos MC, Diederen BM, Vandenbroucke-Grauls CM, Voss A, Kluytmans JA, et al. Dutch guideline on the laboratory detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2014;33(1):89–101.PubMedCrossRef Kluytmans-van den Bergh MF, Vos MC, Diederen BM, Vandenbroucke-Grauls CM, Voss A, Kluytmans JA, et al. Dutch guideline on the laboratory detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2014;33(1):89–101.PubMedCrossRef
25.
go back to reference Kilic A, Muldrew KL, Tang YW, Basustaoglu AC. Triplex real-time polymerase chain reaction assay for simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci and determination of methicillin resistance directly from positive blood culture bottles. Diagn Microbiol Infect Dis. 2010;66(4):349–55.PubMedCrossRef Kilic A, Muldrew KL, Tang YW, Basustaoglu AC. Triplex real-time polymerase chain reaction assay for simultaneous detection of Staphylococcus aureus and coagulase-negative staphylococci and determination of methicillin resistance directly from positive blood culture bottles. Diagn Microbiol Infect Dis. 2010;66(4):349–55.PubMedCrossRef
26.
go back to reference Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29(5):1128–32.PubMedCrossRef Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29(5):1128–32.PubMedCrossRef
27.
go back to reference Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-valentine leukocidin. Lab Investig. 2007;87(1):3–9.PubMedCrossRef Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-valentine leukocidin. Lab Investig. 2007;87(1):3–9.PubMedCrossRef
28.
go back to reference Schouls LM, Spalburg EC, van Luit M, Huijsdens XW, Pluister GN, van Santen-Verheuvel MG, et al. Multiple-locus variable number tandem repeat analysis of Staphylococcus aureus: comparison with pulsed-field gel electrophoresis and spa-typing. PLoS One. 2009;4(4):e5082.PubMedPubMedCentralCrossRef Schouls LM, Spalburg EC, van Luit M, Huijsdens XW, Pluister GN, van Santen-Verheuvel MG, et al. Multiple-locus variable number tandem repeat analysis of Staphylococcus aureus: comparison with pulsed-field gel electrophoresis and spa-typing. PLoS One. 2009;4(4):e5082.PubMedPubMedCentralCrossRef
29.
go back to reference Vieira MT, Marlow MA, Aguiar-Alves F, Pinheiro MG, Freitas Alves Mde F, Santos Cruz ML, et al. Living conditions as a driving factor in persistent methicillin-resistant Staphylococcus aureus colonization among HIV-infected youth. Pediatr Infect Dis J. 2016;35(10):1126–31.PubMedCrossRef Vieira MT, Marlow MA, Aguiar-Alves F, Pinheiro MG, Freitas Alves Mde F, Santos Cruz ML, et al. Living conditions as a driving factor in persistent methicillin-resistant Staphylococcus aureus colonization among HIV-infected youth. Pediatr Infect Dis J. 2016;35(10):1126–31.PubMedCrossRef
30.
go back to reference Larsson AK, Gustafsson E, Nilsson AC, Odenholt I, Ringberg H, Melander E. Duration of methicillin-resistant Staphylococcus aureus colonization after diagnosis: a four-year experience from southern Sweden. Scand J Infect Dis. 2011;43(6–7):456–62.PubMedCrossRef Larsson AK, Gustafsson E, Nilsson AC, Odenholt I, Ringberg H, Melander E. Duration of methicillin-resistant Staphylococcus aureus colonization after diagnosis: a four-year experience from southern Sweden. Scand J Infect Dis. 2011;43(6–7):456–62.PubMedCrossRef
31.
go back to reference Robicsek A, Beaumont JL, Peterson LR. Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2009;48(7):910–3.PubMedCrossRef Robicsek A, Beaumont JL, Peterson LR. Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2009;48(7):910–3.PubMedCrossRef
32.
go back to reference Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis. 2001;32(10):1393–8.PubMedCrossRef Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis. 2001;32(10):1393–8.PubMedCrossRef
33.
go back to reference Ravensbergen SJ, Louka C, Ott A, Rossen JW, Cornish D, Pournaras S, et al. Proportion of asylum seekers carrying multi-drug resistant microorganisms is persistently increased after arrival in the Netherlands. Antimicrob Resist Infect Control. 2019;8:6.PubMedPubMedCentralCrossRef Ravensbergen SJ, Louka C, Ott A, Rossen JW, Cornish D, Pournaras S, et al. Proportion of asylum seekers carrying multi-drug resistant microorganisms is persistently increased after arrival in the Netherlands. Antimicrob Resist Infect Control. 2019;8:6.PubMedPubMedCentralCrossRef
34.
go back to reference Lekkerkerk WSN, Haenen A, van der Sande MAB, Leenstra T, de Greeff S, Timen A, et al. Newly identified risk factors for MRSA carriage in the Netherlands. PLoS One. 2017;12(11):e0188502.PubMedPubMedCentralCrossRef Lekkerkerk WSN, Haenen A, van der Sande MAB, Leenstra T, de Greeff S, Timen A, et al. Newly identified risk factors for MRSA carriage in the Netherlands. PLoS One. 2017;12(11):e0188502.PubMedPubMedCentralCrossRef
35.
go back to reference El-Sharif A, Ashour HM. Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) colonization and infection in intravenous and inhalational opiate drug abusers. Exp Biol Med (Maywood). 2008;233(7):874–80.CrossRef El-Sharif A, Ashour HM. Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) colonization and infection in intravenous and inhalational opiate drug abusers. Exp Biol Med (Maywood). 2008;233(7):874–80.CrossRef
37.
go back to reference Dangerfield B, Chung A, Webb B, Seville MT. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother. 2014;58(2):859–64.PubMedPubMedCentralCrossRef Dangerfield B, Chung A, Webb B, Seville MT. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother. 2014;58(2):859–64.PubMedPubMedCentralCrossRef
Metadata
Title
Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) among undocumented migrants and uninsured legal residents in Amsterdam, the Netherlands: a cross-sectional study
Authors
E. van Dulm
S. Klok
A. Boyd
I. K. Joore
M. Prins
A. P. van Dam
G. A. Tramper-Stranders
Y. T. H. P. van Duijnhoven
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Antibiotic
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2020
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-020-00785-8

Other articles of this Issue 1/2020

Antimicrobial Resistance & Infection Control 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine